The Institute of Cancer Research Clinical Trials & Statistics Unit (ICR-CTSU) is expanding its statistical team with an exciting opportunity for an enthusiastic, motivated Trials Methodologist/Senior Trials Methodologist.
We want to hear from you if you:
* Enjoy the challenge of researching, developing, and implementing efficient trial methodology that would make a difference in patients’ lives.
* Seek variety in your work and opportunities to apply your statistical knowledge across multiple therapeutic areas in oncology.
* Thrive on being part of a multi-disciplinary research team with like-minded statisticians.
Trials Methodologist/Senior Trials Methodologist
Salary Range: £41,607 – £46,724 per annum
Full time; Part time (minimum 60% FTE) will be considered.
Length of Contract: Fixed Term for 24 months
Closing Date: 19th September 2023
Link to apply: https://jobs.icr.ac.uk/vacancies/706/trials-methodologist-senior-trials-methodologist.html
Potential interview dates: 3rd/4th October 2023
For informal discussion about the Trials Methodologist/Senior Trials Methodologist post, please contact Professor Christina Yap, email: christina.yap@icr.ac.uk.
For general queries about the recruitment process, please contact ICR-CTSU, email: ctsu@icr.ac.uk.
Summary of Role
The Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU)<https://www.icr.ac.uk/our-research/centres-and-collaborations/centres-at-the-icr/clinical-trials-and-statistics-unit> is expanding its statistical and methodology team of over 20 statisticians at its Sutton site in Surrey. ICR-CTSU manages an exciting portfolio of national and international phase II and III clinical trials and an expanding number of early phase I/II cancer trials.
The post-holder will have a dual role: (a) developing novel methodologies in the design and analysis of clinical trials, and (b) applying efficient methods in new and ongoing trials. They will work as part of a multi-disciplinary team on trials methodology research, as well as the statistical development, oversight and analysis of a number of clinical trials within ICR-CTSU’s portfolio and the early phase portfolio in collaboration with the Drug Development Unit at ICR and Royal Marsden, and external organisations. Under the guidance of principal statisticians and the ICR-CTSU Scientific/Methodology Lead, they will work across a varied portfolio across all trial phases, with a primary focus in developing and implementing efficient trial methodology in early phase and adaptive trials.
Key Requirements
The successful applicant will be an experienced and highly motivated statistician interested in researching new statistical methods to improve efficiency in clinical trials and eager to apply their statistical knowledge across various therapeutic areas in oncology. They will have a post-graduate qualification in statistics. They should demonstrate a solid understanding of clinical trials and experience in applying statistical methods to real-world data. Familiarity with Bayesian statistics is highly desirable. Effective oral and written communication skills, along with enthusiasm for collaborating with others from diverse disciplines, are essential.
Additional information
Appointment will be on a fixed term contract for 2 years. We currently have a blended approach to home and office working, and flexible working options may be considered.
When applying please provide a supporting statement detailing why you are applying for this position and detailing your relevant experience; together with your CV including details of your current salary and the names and addresses of two referees.
This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application and health surcharge If you are considering relocating to the UK, further information can be found here<https://www.icr.ac.uk/careers/working-at-the-icr/moving-to-the-uk>.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.
The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company Limited by Guarantee, Registered in England under Company No. 534147 with its Registered Office at 123 Old Brompton Road, London SW7 3RP.
The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company Limited by Guarantee, Registered in England under Company No. 534147 with its Registered Office at 123 Old Brompton Road, London SW7 3RP.
This e-mail message is confidential and for use by the addressee only. If the message is received by anyone other than the addressee, please return the message to the sender by replying to it and then delete the message from your computer and network.
